AI assistant
SURMODICS INC — Director's Dealing 2021
Feb 3, 2021
32845_dirs_2021-02-03_622083b2-3c3b-42c3-b3d5-b156d5d2775a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2021-02-01
Reporting Person: Maharaj Gary R (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-01 | Common Stock | S | 2843 | $44.7672 | Disposed | 142299 | Direct |
| 2021-02-01 | Common Stock | S | 157 | $45.54 | Disposed | 142142 | Direct |
Footnotes
F1: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2020.
F2: Reflects the weighted average price of 2,843 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on February 1, 2021 with sale prices ranging from $44.50 to $45.38 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.